137 related articles for article (PubMed ID: 8696946)
21. Effects of interleukin-6 on the expression of thyroid hormone-binding protein genes in cultured human hepatoblastoma-derived (Hep G2) cells.
Bartalena L; Farsetti A; Flink IL; Robbins J
Mol Endocrinol; 1992 Jun; 6(6):935-42. PubMed ID: 1323058
[TBL] [Abstract][Full Text] [Related]
22. Albumin inhibits apolipoprotein AI and AII production in human hepatoblastoma cell line (Hep G2): additive effects of oleate-albumin complex.
Sakai T; Jin FY; Kamanna VS; Kashyap ML
Atherosclerosis; 2000 Mar; 149(1):43-9. PubMed ID: 10704613
[TBL] [Abstract][Full Text] [Related]
23. Regulation of apolipoprotein A-I gene expression in Hep G2 cells depleted of Cu by cupruretic tetramine.
Wu JY; Zhang JJ; Wang Y; Reaves SK; Wang YR; Lei PP; Lei KY
Am J Physiol; 1997 Oct; 273(4):C1362-70. PubMed ID: 9357782
[TBL] [Abstract][Full Text] [Related]
24. Dietary cholic acid lowers plasma levels of mouse and human apolipoprotein A-I primarily via a transcriptional mechanism.
Srivastava RA; Srivastava N; Averna M
Eur J Biochem; 2000 Jul; 267(13):4272-80. PubMed ID: 10866832
[TBL] [Abstract][Full Text] [Related]
25. Identification of a sequence of apolipoprotein A-I associated with the efflux of intracellular cholesterol to human serum and apolipoprotein A-I containing particles.
Sviridov D; Pyle L; Fidge N
Biochemistry; 1996 Jan; 35(1):189-96. PubMed ID: 8555173
[TBL] [Abstract][Full Text] [Related]
26. ApoA-I knockout mice: characterization of HDL metabolism in homozygotes and identification of a post-RNA mechanism of apoA-I up-regulation in heterozygotes.
Plump AS; Azrolan N; Odaka H; Wu L; Jiang X; Tall A; Eisenberg S; Breslow JL
J Lipid Res; 1997 May; 38(5):1033-47. PubMed ID: 9186920
[TBL] [Abstract][Full Text] [Related]
27. Actions of 3,5,3'-tri-iodothyronine on the synthesis and secretion of major plasma proteins by a human hepatoblastoma cell line (Hep G2).
Kobayashi M; Horiuchi R
J Mol Endocrinol; 1995 Apr; 14(2):227-35. PubMed ID: 7542451
[TBL] [Abstract][Full Text] [Related]
28. RVX-208: a small molecule that increases apolipoprotein A-I and high-density lipoprotein cholesterol in vitro and in vivo.
Bailey D; Jahagirdar R; Gordon A; Hafiane A; Campbell S; Chatur S; Wagner GS; Hansen HC; Chiacchia FS; Johansson J; Krimbou L; Wong NC; Genest J
J Am Coll Cardiol; 2010 Jun; 55(23):2580-9. PubMed ID: 20513599
[TBL] [Abstract][Full Text] [Related]
29. Influence of apolipoprotein A-I and apolipoprotein A-II availability on nascent HDL heterogeneity.
Alexander ET; Phillips MC
J Lipid Res; 2013 Dec; 54(12):3464-70. PubMed ID: 24089247
[TBL] [Abstract][Full Text] [Related]
30. Effects of dimethyl sulfoxide on apolipoprotein A-I in the human hepatoma cell line, HepG2.
Tam SP; Zhang X; Cuthbert C; Wang Z; Ellis T
J Lipid Res; 1997 Oct; 38(10):2090-102. PubMed ID: 9374131
[TBL] [Abstract][Full Text] [Related]
31. Deletions of helices 2 and 3 of human apoA-I are associated with severe dyslipidemia following adenovirus-mediated gene transfer in apoA-I-deficient mice.
Chroni A; Kan HY; Shkodrani A; Liu T; Zannis VI
Biochemistry; 2005 Mar; 44(10):4108-17. PubMed ID: 15751988
[TBL] [Abstract][Full Text] [Related]
32. LCAT can rescue the abnormal phenotype produced by the natural ApoA-I mutations (Leu141Arg)Pisa and (Leu159Arg)FIN.
Koukos G; Chroni A; Duka A; Kardassis D; Zannis VI
Biochemistry; 2007 Sep; 46(37):10713-21. PubMed ID: 17711302
[TBL] [Abstract][Full Text] [Related]
33. Relationship between low-density lipoprotein size and apolipoprotein A-I-containing particles: the ECTIM study.
Luc G; Bard JM; Poulain P; Arveiler D; Evans AE; Cambien F; Fruchart JC; Ducimetière P
Eur J Clin Invest; 1997 Mar; 27(3):242-7. PubMed ID: 9088861
[TBL] [Abstract][Full Text] [Related]
34. ApoA-IHelsinki (Lys107-->0) associated with reduced HDL cholesterol and LpA-I:A-II deficiency.
Tilly-Kiesi M; Zhang Q; Ehnholm S; Kahri J; Lahdenperä S; Ehnholm C; Taskinen MR
Arterioscler Thromb Vasc Biol; 1995 Sep; 15(9):1294-306. PubMed ID: 7670941
[TBL] [Abstract][Full Text] [Related]
35. Elevated hepatic apolipoprotein A-I transcription is associated with diet-induced hyperalphalipoproteinemia in rabbits.
Schwab DA; Rea TJ; Hanselman JC; Bisgaier CL; Krause BR; Pape ME
Life Sci; 2000 Mar; 66(18):1683-94. PubMed ID: 10809165
[TBL] [Abstract][Full Text] [Related]
36. Structure-function relationships in reconstituted HDL: Focus on antioxidative activity and cholesterol efflux capacity.
Cukier AMO; Therond P; Didichenko SA; Guillas I; Chapman MJ; Wright SD; Kontush A
Biochim Biophys Acta Mol Cell Biol Lipids; 2017 Sep; 1862(9):890-900. PubMed ID: 28529180
[TBL] [Abstract][Full Text] [Related]
37. Effect of apolipoprotein A-I lipidation on the formation and function of pre-beta and alpha-migrating LpA-I particles.
Sparks DL; Frank PG; Braschi S; Neville TA; Marcel YL
Biochemistry; 1999 Feb; 38(6):1727-35. PubMed ID: 10026251
[TBL] [Abstract][Full Text] [Related]
38. Human apolipoprotein A-II enrichment displaces paraoxonase from HDL and impairs its antioxidant properties: a new mechanism linking HDL protein composition and antiatherogenic potential.
Ribas V; Sánchez-Quesada JL; Antón R; Camacho M; Julve J; Escolà-Gil JC; Vila L; Ordóñez-Llanos J; Blanco-Vaca F
Circ Res; 2004 Oct; 95(8):789-97. PubMed ID: 15388641
[TBL] [Abstract][Full Text] [Related]
39. Cloning and characterization of a novel apolipoprotein A-I binding protein, AI-BP, secreted by cells of the kidney proximal tubules in response to HDL or ApoA-I.
Ritter M; Buechler C; Boettcher A; Barlage S; Schmitz-Madry A; Orsó E; Bared SM; Schmiedeknecht G; Baehr CH; Fricker G; Schmitz G
Genomics; 2002 May; 79(5):693-702. PubMed ID: 11991719
[TBL] [Abstract][Full Text] [Related]
40. Different effects of subclasses of HDL containing apoA-I but not apoA-II (LpA-I) on cholesterol esterification in plasma and net cholesterol efflux from foam cells.
Ohta T; Saku K; Takata K; Nakamura R; Ikeda Y; Matsuda I
Arterioscler Thromb Vasc Biol; 1995 Jul; 15(7):956-62. PubMed ID: 7600128
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
